Arthneeti
Latest: Rama Phosphates Q1 FY27 results →All Q3 FY26 results →
RP

Rama Phosphates

Q3 FY26

Rama Phosphates Q3 FY26 investor presentation: Revenue & Margins

Q3 FY26 investor presentation: what the company reported on revenue, margins and capex.

Price₹109
Market cap₹385 Cr
P/E7.2
Updated16 Oct 2026
Read4 min read

Based on Rama Phosphates's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Q3 FY26 Revenue from Operations: ₹23,800 lakhs, up 33% YoY (Q3 FY25: ₹17,962 lakhs) [Page 9] - PAT for Q3 FY26: ₹1,403 lakhs, up 283% YoY (Q3 FY25: ₹366 lakhs) [Page 9] - 9M FY26 Revenue from Oper Q3 EBITDA: ₹2,414 Lacs (up 134% YoY from ₹1,032 Lacs in Q3 FY25) [Page 9] - Q3 PAT: ₹1,403 Lacs (up 283% YoY from ₹366 Lacs in Q3 FY25) [Page 9] - However, revenue from operations for Q3 FY26 is ₹23,800 Lacs, indicating EBITDA margin ≈ 10.1% (2,414/23,800) [Pages 9 and 7] - Year-on-Year Revenue: ₹23,800 Lacs in Q3 FY26 vs ₹17,962 Lacs in Q3 FY25 (33% increase) [Pages 7 and 9] - However, Page 10 mentions "Operational Efficiency, Proactive R&D & Leveraging technology contributed to outstanding financial results" and "Robust Financial performance," implying a positive margin outlook.

From Rama Phosphates's Q3 FY26 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

  • Q3 FY26 Revenue from Operations: ₹23,800 lakhs, up 33% YoY (Q3 FY25: ₹17,962 lakhs) [Page 9]
  • PAT for Q3 FY26: ₹1,403 lakhs, up 283% YoY (Q3 FY25: ₹366 lakhs) [Page 9]
  • 9M FY26 Revenue from Operations: ₹67,397 lakhs, up 24% YoY (9M FY25: ₹54,277 lakhs) [Page 9]
  • 9M FY26 PAT: ₹4,734 lakhs, up 462% YoY (9M FY25: ₹842 lakhs) [Page 9]

2 more points from Rama Phosphates's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Rama Phosphates said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Dhule Phase 1 Project: ₹35.05 Cr CAPEX incurred till Q3 FY26 (₹4.85 Cr funded through term loan). Trial production of SSP expected by end of Q4 FY26.
  • Dhule Phase 2 Project: Sulphuric Acid plant with proposed capacity of 90,000 MT. Construction expected from late April 2026 to March 2027. Total project cost ₹30 Cr.
  • Capacity expansions at existing plants:
  • Fertilizer plant expansion from 132,000 MT PA to 181,000 MT PA at Udaipur (historical).
  • Fertilizer plant expansion from 165,000 MT PA to 250,000 MT PA at Indore (historical).

2 more points from Rama Phosphates's call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

See what Rama Phosphates said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

It highlights: - Renewal of FY26 SSP contract with Hindustan Urvarak & Rasayan Limited (HURL) for approximately 1 lakh MT, reinforcing revenue stability (Page 10). - Strong revenue growth and operational efficiency reflected in financial results (Pages 7-9).

2 more points from Rama Phosphates's call on order book

Create a free account to keep reading this call

Rama Phosphates — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹219 Cr, net profit ₹5 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Rama Phosphates Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

  • Bhagiradha Chemicals & Industries Ltd (Q3 FY26)

    114.0 crore, up 11% YoY from Rs. Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q3 FY26 investor presentation — and how it ran

  • Advance Agrolife Ltd (Q3 FY26)

    Q3 FY26 revenue from operations was ₹1,338 million, up 18% year-on-year (YoY) from ₹1,134 million in Q3 FY25 (Pages 23-24). Key investor presentation takeaways

  • Khaitan Chemicals & Fertilizers Ltd (Q3 FY26)

    Q3-FY26 operational revenue: INR 2,657 million, up 34% year-on-year (Page 23, 24). Key investor presentation takeaways from Khaitan Chemical's Q3 FY26 investor

  • Sumitomo Chemical India Ltd (Q3 FY26)

    568.0 crore, down 12% year-on-year from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q3 FY26 earnings call — and how it ranks against sector…

Compare:vs Coromandel Intervs UPL Ltdvs F A C T

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Rama Phosphates and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Rama Phosphates Q3 FY26 results?

Q3 FY26 Revenue from Operations: ₹23,800 lakhs, up 33% YoY (Q3 FY25: ₹17,962 lakhs) [Page 9] - PAT for Q3 FY26: ₹1,403 lakhs, up 283% YoY (Q3 FY25: ₹366 lakhs) [Page 9] - 9M FY26 Revenue from Oper Q3 EBITDA: ₹2,414 Lacs (up 134% YoY from ₹1,032 Lacs in Q3 FY25) [Page 9] - Q3 PAT: ₹1,403 Lacs (up 283% YoY from ₹366 Lacs in Q3 FY25) [Page 9] - However, revenue from operations for Q3 FY26 is ₹23,800 Lacs, indicating EBITDA margin ≈ 10.1% (2,414/23,800) [Pages 9 and 7] - Year-on-Year Revenue: ₹23,800 Lacs in Q3 FY26 vs ₹17,962 Lacs in Q3 FY25 (33% increase) [Pages 7 and 9] - However, Page 10 mentions "Operational Efficiency, Proactive R&D & Leveraging technology contributed to outstanding financial results" and "Robust Financial performance," implying a positive margin outlook.

What is Rama Phosphates share price analysis?

Rama Phosphates currently shows a neutral. The stock trades at a P/E of 7.2 with a market cap of ₹385 Cr. Investors should review the full earnings analysis for detailed insights.

Is Rama Phosphates planning capital expenditure?

Dhule Phase 1 Project: ₹35.05 Cr CAPEX incurred till Q3 FY26 (₹4.85 Cr funded through term loan).

Keep Rama Phosphates on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.